Quick jump to page content
  • Main Navigation
  • Main Content
  • Sidebar
  • Register
  • Login
##common.pageHeaderLogo.altText##
  • Home
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Current
  • Archives
  • Submission

Search

Advanced filters

Search Results

Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study

Gordon Sussman, Jacques Hebert, Wayne Gulliver, Charles Lynde, William H Yang, Olivier Chambenoit, Antonio Vieira, Frederica De Takacsy, Lenka Rihakova

Page s127

Poster PDF

Design and rational of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU)

Gordon Sussman, Jacques Hebert, Wayne Gulliver, Charles Lynde, William H Yang, Olivier Chambenoit, Gretty Deutsch, Frederica DeTakacsy, Lenka Rihakova

Page s125

Poster PDF

Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study

Gordon Sussman, Jacques Hebert, Wayne Gulliver, Charles Lynde, William H Yang, Olivier Chambenoit, Antonio Vieira, Frederica DeTakaosy, Lenka Rihakova

Page S54

Poster PDF

Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study

Karsten Weller, Petra Staubach, Martin Metz, Nadine Chapman-Rothe, Christian Sieder, Matthias Brautigam, Marcus Maurer

Page S53

Poster PDF

Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study

Wayne Gulliver, Gordon Sussman, Jacques Hebert, Charles W Lynde, Kim A Papp, William H Yang, Olivier Chambenoit, Antonio Viera, Frederica DeTakaosy, Lenka Rihakova

Page S52

Poster PDF
1 - 5 of 5 items

 

 

 

 

180x77

Make a Submission

SKIN is a bi-monthly, peer-reviewed, online medical journal dedicated to providing an enhanced route to disseminate new dermatologic knowledge on all aspects of cutaneous disease. The Journal is Open Access. ISSN: 2574-1624

Important Links

  • About the Journal
  • Editorial Team
  • Submissions
  • Contact

Contact

  • Email: jofskin@gmail.com
  • Website: www.jofskin.org
  • Mailing Address: PO Box 569 Millwood NY 10546
OJS Hosting, Support, and Customization by: OpenJournalSystems.com

Modal Header